Inflammation and cardiovascular disease: From mechanisms to therapeutics

Inflammation constitutes a complex, highly conserved cascade of molecular and cellular events. Inflammation has been labeled as “the fire within,” is highly regulated, and is critical to host defense and tissue repair. In general, inflammation is beneficial and has evolved to promote survival. Howev...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:American journal of preventive cardiology Ročník 4; s. 100130
Hlavní autoři: Alfaddagh, Abdulhamied, Martin, Seth S., Leucker, Thorsten M., Michos, Erin D., Blaha, Michael J., Lowenstein, Charles J., Jones, Steven R., Toth, Peter P.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Elsevier B.V 01.12.2020
Elsevier
Témata:
Atherosclerosis
C-reactive protein
Cardiovascular
Cardiovascular disease
Cytokine
Inflammasome
Inflammation
Interleukin
Lipoprotein
Microbiome
State-of-the-Art Review
C-reactive protein
Interleukin
Atherosclerosis
Cytokine
Cardiovascular disease
Inflammasome
Inflammation
Lipoprotein
Microbiome
ISSN:2666-6677, 2666-6677
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Inflammation constitutes a complex, highly conserved cascade of molecular and cellular events. Inflammation has been labeled as “the fire within,” is highly regulated, and is critical to host defense and tissue repair. In general, inflammation is beneficial and has evolved to promote survival. However, inflammation can also be maladaptive when chronically activated and sustained, leading to progressive tissue injury and reduced survival. Examples of a maladaptive response include rheumatologic disease and atherosclerosis. Despite evidence gathered by Virchow over 100 years ago showing that inflammatory white cells play a role in atherogenesis, atherosclerosis was until recently viewed as a disease of passive cholesterol accumulation in the subendothelial space. This view has been supplanted by considerable basic scientific and clinical evidence demonstrating that every step of atherogenesis, from the development of endothelial cell dysfunction to foam cell formation, plaque formation and progression, and ultimately plaque rupture stemming from architectural instability, is driven by the cytokines, interleukins, and cellular constituents of the inflammatory response. Herein we provide an overview of the role of inflammation in atherosclerotic cardiovascular disease, discuss the predictive value of various biomarkers involved in inflammation, and summarize recent clinical trials that evaluated the capacity of various pharmacologic interventions to attenuate the intensity of inflammation and impact risk for acute cardiovascular events.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:2666-6677
2666-6677
DOI:10.1016/j.ajpc.2020.100130